Glatt Pharmaceutical Services is an oral solids CDMO with an exceptional compliance history that specializes in the formulation development and process optimization of hard to craft formulations and challenging modified release profiles. Glatt’s core technologies include solubility enhancement via production of ASDs using fluid bed technology, taste masking, and complex multi-particulate dosage forms - all developed with robust, stable, scalable pharmaceutical processes. Glatt offers large scale solvent processing and handles DEA substances schedule l through V. Glatt has you covered from small scale development through seamless scale up to large scale commercial manufacturing.